Rebirth 08: Rise from copycat phones

Chapter 653 ARE78 User List

In a building in a coastal city in Africa, the sign at the entrance, "East Africa Pharmaceuticals," is quite eye-catching.

According to publicly available corporate information, East Africa Pharmaceuticals is a wholly-owned subsidiary of French company East Africa Pharmaceuticals. It has established a small pharmaceutical manufacturing plant in the local area to produce several low-tech generic drugs whose patents have expired.

Such a pharmaceutical factory would be nothing special in Europe, America, China, Japan, South Korea, or even India; it would be considered a very insignificant small pharmaceutical company.

However, such a pharmaceutical company, which has outdated technology but is still able to produce several generic small molecule drugs whose patents have expired, is particularly valuable in this small, underdeveloped coastal country in Africa.

The importance of this factory can be seen from its security measures: it is surrounded by high walls with electrified barbed wire, and there is a tower between the walls with a simulated heavy machine gun visible on it.

Several armored vehicles were parked on the open ground behind the wall.

This pharmaceutical company in East Africa employs Galaxy Security, a well-known security firm in the region, for its daily security services.

Of course, all of the above is the information that is publicly available... This East African Pharmaceutical, along with its parent company, French East Pharmaceutical, are both front-end subsidiaries of Galaxy Life.

Galaxy Life established more than ten white-glove companies worldwide to facilitate financial operations, establish, protect, and conceal research and development bases, provide legal benefits and protections for employees developing its secret projects, commercialize some research projects, and ultimately, facilitate and improve clinical trials for some projects.

Among them, the most well-known is Huaxia Yinhe Pharmaceutical, which is ostensibly a joint venture between South Africa and China. However, people in the world's elite circles know that it is a legitimate commercialization project of Yinhe Life, mainly engaged in the commercialization of Yinhe Life's legitimate research results. Its core products are the broad-spectrum anticancer drug "Xeloda" and "neuroimmune enhancers"... At the same time, it also engages in some conventional drug and medical device businesses. In addition, in recent years, its MRI equipment has become number one in the world, and it is also a world-leading artificial intelligence company in the medical field.

In addition to Huaxia Yinhe Pharmaceutical, Yinhe Life also owns three other large pharmaceutical companies: European Eastern France Pharmaceutical, American Croda Biotechnology, and Indian Andar Pharmaceutical. These three companies have revenues in the billions of dollars, which is quite substantial.

The above four are the large, publicly known white-glove companies. Galaxy Life also has a whole bunch of other unrelated white-glove companies under its umbrella, which are harder to categorize.

East Africa Pharmaceuticals is a subsidiary of East France Pharmaceuticals in Europe... Therefore, legally speaking, this pharmaceutical factory is actually French property.

However, this East Africa Pharmaceutical is just a cover. In fact, there is another sign in the underground floor of this East Africa Pharmaceutical: Galaxy Life Eighth Research Institute!

One of the thirteen major research institutes under Galaxy Life worldwide, primarily engaged in research on the ARE78 project and other anti-aging projects.

As the clinical trials of the ARE78 project are gradually completed, the importance of the ARE78 project is constantly increasing, which in turn leads to the increasing importance of the Eighth Research Institute.

Previously, only the institute's management and researchers were stationed at the Eighth Research Institute, but now, a director of Galaxy Life's Africa Executive Committee is stationed here year-round to manage the institute.

Today, in the underground conference room of the Eighth Research Institute, seven or eight senior managers and core scientists are holding a very important meeting.

That is to discuss the Phase IV clinical trial of the ARE78 project!

"Since the start of the Phase IV clinical trial, we have selected more than 1,500 participants, in four age groups: 50, 60, 70, and 80 years and older!"

"We conducted a double-blind, controlled trial, and the first phase of the trial is now complete, based on the data we collected!"

"In the first batch of experiments, the effectiveness of ARE78 reached 100%. All the participants who used the drug experienced varying degrees of improvement in their physical functions. The most significant case was a 78-year-old participant who, after long-term use, a balanced diet, and appropriate scientific exercise, has now recovered to the average level of a 55-year-old man!"

"In other words, the physical function recovery in this case lasted for twenty-three years. This is a very remarkable case, even exceeding our expectations!"

"In other cases, generally speaking, the recovery of physical function is more obvious in older patients. For example, in the group of people over seventy years old, the recovery period can generally reach more than fifteen years."

"In the relatively younger 50-year-old group, the average recovery time for physical function is about five years!"

"This is because younger people generally have higher physical functions, so their recovery rate is relatively limited. However, older people have significantly weakened physical functions, so with the support of our ARE78 drug, they can achieve better recovery results!"

"After all, our ARE78 drug doesn't create something out of nothing by directly enhancing people's physical abilities, nor can it allow people to break through their physical limits. It only slows down and delays the aging process, maintaining the level of bodily functions as much as possible!"

"And in this experiment, we have once again verified that the ARE78 drug does not possess any lifespan extension properties!"

"Regarding medication safety, we have gradually figured out some characteristics of the drug's side effects. Some diseases in the human body can affect the drug's efficacy and may even lead to severe conflicts and serious side effects!"

"Therefore, based on the experimental results, we have compiled a detailed list of eight diseases in which this drug is not suitable!"

"In addition, in the healthy group, a small number of participants experienced drowsiness, itching, or even fainting while using the drug, but no obvious adverse side effects were observed."

"In the healthy group, the majority of those who took ARE78 experienced no side effects, reaching an overall rate of 87%!"

"In the patient group, there are no conflicts among many common chronic diseases. The main conflicts are among some less common diseases, such as cancer patients. They cannot take our ARE78 drug, otherwise, the ARE78 drug will stimulate the tumor to grow faster, which is extremely dangerous to life!"

"Of course, most cancers can now be treated with Xelocta. Patients who recover after Xelocta treatment will not face this risk when using our ARE78 drug."

"Overall, with thorough prior testing to rule out diseases, and by reducing the dosage during the initial course of medication while maintaining close monitoring, and discontinuing medication immediately upon the occurrence of side effects, there is no real risk!"

"The real risk lies in the withdrawal symptoms after long-term use... To date, we still haven't been able to resolve the side effects of stopping ARE78!"

"Based on our long-term research and observation, our technical team believes that after people take ARE78, many systems in the body, especially the metabolic system, produce a large number of younger and more vibrant cells using a completely new mechanism, replacing the old cells that were previously in the aging mode."

"Human metabolism follows natural laws, and as we age, many characteristics of the new cells produced by metabolism weaken. However, with the stimulation of our ARE78 drug, the new cells produced by the metabolic system become more active and healthier!"

"Therefore, for our ARE78 drug to be effective, patients need to take it long-term, while simultaneously maintaining nutritional supplements and appropriate healthy exercise. Then, we can see that the body's functions become healthier and better!" "However, once the drug is stopped, the body's major subsystems, especially the metabolic system, will return to the levels that should be present at this age. Under such circumstances, the newly produced cells of the body will show a significant weakening in various performance characteristics!"

"This will cause many problems that would not have occurred under normal healthy physical conditions to erupt in a short period of time, thus triggering a series of health problems!"

"To be precise, this is not actually a side effect of our ARE78 drug itself, but rather that after stopping the drug, the body's functions return to their original age in a short period of time... and as people get older, they will naturally develop various diseases!"

"It just came on so suddenly that we initially mistook it for a side effect of the drug itself. But after long-term research and analysis, we have confirmed that it is not a defect or side effect of the drug, but a natural reaction of the human body!"

"Therefore, withdrawal reactions are almost unavoidable and cannot be resolved technically!"

"The only solution is to resume taking the medication!"

"Of course, various medical measures can be taken in advance to alleviate the side effects after stopping the medication, and then gradually restore the patient to the health level that should be expected for their age..."

"Overall, our ARE78 drug is now ready for practical application. Of course, to ensure medication safety, we need to strictly follow all standards and conduct pre-administration drug testing."

"Under strict medication standards, our ARE78 drug has already demonstrated practical application value!"

"In addition, based on the successful experience of ARE78, we are continuing to develop a second-generation drug, with the main goal of avoiding conflicts with a variety of diseases, further reducing side effects, and expanding the scope of application!"

"In addition, we are actively exploring better solutions to the side effects after discontinuing medication!"

A technical meeting at the Eighth Research Institute was quickly organized, and the meeting report was then submitted to Xu Shenxue.

After receiving the latest technical report for the ARE78 project, Xu Shenxue thought about it and made a decision to allow the ARE78 project to select suitable groups for use on a small scale.

After Xu Shenxue officially approved the drug's use, Galaxy Life also launched related actions.

Not long after, a financial oligarch in Eastern Europe met a mysterious young man at his private estate.

The last time this mysterious young man came, he took three hundred million dollars from him!
What he received was the right to prioritize the purchase and use of drugs or technologies developed by Galaxy Life.

In short, this financial oligarch spent $300 million to buy a ticket... The key point is that he doesn't even know the specifics of Galaxy Life, or even where the company is located!
Why did he so readily hand over the money? It's because a higher-level conglomerate tycoon introduced him to the program... These top-tier life projects are so rare that even the wealthiest people can't find the entrance, let alone donate to them.

This financial oligarch is quite old and cares a lot about things like combating aging. He thinks it's good to spend some money to buy a little hope, even if there isn't any... But more importantly, after spending money to buy a ticket, he can participate in a higher-level circle: the circle of the world's top financial groups!

Before this, he was already a billionaire with assets worth tens of billions of US dollars, but he had no idea that there was such a project as Galaxy Life...

The social circle is still too small!
Now, this young man, who claims to be from Galactic Life, has come here again, but this time not to ask for money. Instead, he tells him that an anti-aging project in Galactic Life has achieved a stage of success.

Currently, a limited-scale use phase is open, and we are asking if he is willing to participate. If he wants to participate, he needs to submit a comprehensive medical and health report for review. As long as he passes the medical and health review and meets the conditions for using the ARE78 project, he can be selected.

It also included a series of usage restrictions, including the fact that patients with various diseases cannot use it, and pointed out that the project still has certain risks. Please be sure to submit all kinds of medical information truthfully... Of course, if he passes the initial review, Galaxy Life will arrange for him to undergo a comprehensive medical examination to ensure that he meets the usage conditions.

Upon closer inspection, the financial oligarch realized it was an anti-aging project, and the other party verbally claimed that the project could restore the body's functions to a level comparable to that of ten years.

They also informed them that the annual usage fee for the project is 13 million US dollars per year!

Although he was very skeptical and hesitant, he eventually agreed to conduct the preliminary review and began contacting other top-tier wealthy individuals he had met after entering the Galactic Life Circle.

He secretly contacted several people, especially the head of the top conglomerate who had introduced him to Galactic Life, and couldn't help but feel hopeful.

This time, it seems Galaxy Life is serious; they're really going to develop an anti-aging drug.

Since it's true, we can't let this opportunity slip by. It can make you ten or even twenty years younger, so this is a great opportunity that we absolutely shouldn't miss.

Especially since he is already eighty years old, if he could be ten years younger, he could recover the physical functions he had at seventy years old, which would be a huge improvement for him and a great improvement in his quality of life.

As for the annual fee of just over ten million US dollars, that's nothing at all!
Before long, the financial oligarch was informed that he had passed the initial review and was then told to travel to a certain city at a specified time for further testing.

Several days later, the financial oligarch arrived in a city in western Europe, where he underwent a series of detailed medical examinations by staff from Galactic Life.

That evening, he was informed that he had passed the final review and could participate in the project.

After he readily signed a check for 13 million US dollars, he was taken to Africa on a private plane.

He will undergo further medical examinations in Africa and will also need to provide genetic data so that Galaxy Life can prepare targeted drugs based on his individual genes and conduct preliminary drug observations... to avoid any severe side effects that could kill him!
A large portion of Galaxy Life's research and development funding comes from donations from super-rich individuals around the world. Galaxy Life is quite concerned about the safety of its donors and wants to ensure their safety as quickly as possible, rather than using them as guinea pigs in clinical trials.

This is also why the ARE78 was used on a small scale and under very strict medical and health conditions.

After all, nobody wants to kill their big spenders, and Galaxy Life hopes that the positive feedback from these first batch of big spenders will encourage more super-rich people to donate.

Galaxy Life is also short of money. If we could take advantage of the wave of the first phase of the ARE78 project and raise a donation of tens of billions of dollars, that would be great!

(End of this chapter)